3 results
Determination of possible Alzheimer pathology in the brain and to follow-up participants over time (by means of another research protocol). In addition, its [18F]-label with a half-life of 110 minutes will enable use in hospitals without an on-site…
To evaluate the efficacy of AK002 in adult and adolescent subjects with active EoE when compared to placebo, efficacy endpoints will be co-primary:1) The proportion of subjects who achieve a peak esophageal intraepithelial count of <=6…
The SmartBEAT project aims to address the needs of senior Chronic Heart Failure (CHF) patients and their formal and informal caregivers, by offering an integrated solution to leverage patient self-care through autonomous condition monitoring and…